John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 19,000 shares at $32.94 ($618K) on 2015-06-08, disclosed to the SEC on 2015-06-09.
Scheduled sale ($618k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.50 | 18,400 | $598K | 96.8% |
| 2 | $32.94 | 600 | $20K | 3.2% |
| Total | $32.51 avg | 19,000 | $618K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |